Michael Cobble Selected Research

Dipeptidyl-Peptidase IV Inhibitors

3/2012

Differentiating among incretin-based therapies in the management of patients with type 2 diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Cobble Research Topics

Disease

2	Type 2 Diabetes Mellitus (MODY) 03/2012 - 01/2012
2	Weight Loss (Weight Reduction) 03/2012 - 01/2012
1	Hypertriglyceridemia 03/2020
1	Neoplasms (Cancer) 12/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2019
1	Drug-Related Side Effects and Adverse Reactions 02/2014
1	Nasopharyngitis 03/2012
1	Dyslipidemias (Dyslipidemia) 01/2012
1	Inflammation (Inflammations) 01/2012
1	Hypertension (High Blood Pressure) 01/2012
1	Obesity 01/2012
1	Atherosclerosis 01/2010

Drug/Important Bio-Agent (IBA)

2	Glucagon-Like Peptide-1 ReceptorIBA 03/2012 - 01/2012
2	LipidsIBA 01/2012 - 01/2010
1	CholesterolIBA 03/2020
1	Vitamin D FDA LinkGeneric 12/2019
1	Cholecalciferol (Vitamin D3)FDA Link 12/2019
1	oxidized low density lipoproteinIBA 02/2014
1	Antihypertensive Agents (Antihypertensives)IBA 02/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2014
1	Glucose (Dextrose)FDA LinkGeneric 03/2012
1	Dipeptidyl-Peptidase IV InhibitorsIBA 03/2012
1	IncretinsIBA 03/2012
1	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2012
1	Exenatide (Byetta)FDA Link 01/2012
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2012
1	ApolipoproteinsIBA 01/2012
1	Lipoproteins (Lipoprotein)IBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 01/2010
1	Insulin (Novolin)FDA Link 01/2010

Therapy/Procedure

2	Therapeutics 02/2014 - 03/2012
1	Glycemic Control 01/2012